News Agency
Men's Weekly

GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj.

  • Written by PR Newswire
GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj.
  • Immuncell-LC Inj. is an autologous Cytokine Induced Killer (CIK) cell therapy approved for Commercial use in South Korea as an adjuvant cell therapy for the treatment of Hepatocellular Carcinoma (HCC) after curative resection and has received FDA Orphan Drug Designations (ODDs) for liver, brain, and pancreatic cancers.
  • Immuncell-LC Inj. reduced HCC...

Read more: GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of...

How Family Lawyers Can Help Reduce Conflict During Separation

Separation is rarely straightforward, and the emotional weight it carries can make even practical decisions feel overwhelming. When communication between separating parties breaks down, disputes over property, finances and parenting arrangements can escalate quickly and become far more damaging than... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion